Neonatal drug development addressed in FDA final guidance
Regulatory NewsJoanne S. Eglovitch
BiologicsBiotechnologyChemistry, Manufacturing and Controls (CMC)Clinical TrialsNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy